Matches in SemOpenAlex for { <https://semopenalex.org/work/W68807753> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W68807753 endingPage "71" @default.
- W68807753 startingPage "71" @default.
- W68807753 abstract "With 30 million people on the cusp of receiving health insurance and prescription drug coverage for the first time, thanks to health care reform legislation that Congress may pass, the persistent problems of medication nonadherence and medication errors loom larger than ever. That is the backdrop to the FDA’s current effort to revise its dusty and confusing consumer medication information (CMI) program.CMI refers to the various types of printed materials that pharmacists give patients when they pick up a prescription. Having held a workshop in September, the FDA previewed some potential new CMI formats and then received comments from major drug manufacturers and pharmacy groups. The agency is now on the verge of announcing a new initiative that nearly everyone admits is needed.Janet Woodcock, MD, Director of the FDA’s Center for Drug Evaluation and Research, admits, “We have not made a dent in this epidemic of harm from inappropriate use of drugs or from medication errors.”She notes that a one-document solution is the logical proposal. Currently, the FDA has three different CMI formats; some are mandatory, and some are not. Each format comes into play under different circumstances.“I know we have had lots of discussions and workshops about this over the years, but this time we really mean business,” she adds.The FDA has three types of pharmacy CMI programs. Drug companies voluntarily supply written CMI at the point of purchase for whatever products they choose. The FDA requires patient package inserts (PPIs) to be provided at the pharmacy for only two drug categories: estrogens and oral contraceptives. Paper handouts, called Medication Guides (MedGuides), are required for nearly 90 categories of drugs, all of which have significant risk profiles and could harm a patient if the drug is taken improperly.All three types of CMI have varying formats even though the FDA has published guidance on what they should look like. CMI pamphlets, consisting of sheets stapled to the vial’s bags that the pharmacist gives patients at checkout, are by far the most numerous. However, according to two surveys conducted for the FDA in 2001 and 2008, the number of patients reporting that they received CMI and the number saying that they found the sheets useful were considerably lower than the number of patients required to answer in the affirmative.At this point, even pharmaceutical companies think that the FDA’s consumer drug communication program should be simplified. Some of those companies are particularly concerned about the proliferation of MedGuides since 2007, when Congress passed the FDA Amendments Act (FDAAA). That act allowed the FDA to require companies to develop a Risk Evaluation and Mitigation Strategy (REMS) for drugs with certain risk profiles. Between September 2007 (when the FDAAA was enacted) and May 31, 2009, the FDA approved 50 REMSs with MedGuides, including 43 REMSs consisting only of a MedGuide.Susan Berger, PhD, Senior Director of Risk Management Strategy at Pfizer Inc., claims that the FDA is overusing these guides and that they have become comprehensive-risk communication documents instead of “highly limited information” sheets. More broadly, she argues that any new FDA consumer drug labeling initiative must be carefully limited: Any patient labeling must include only the directions that the patient requires in order to administer the drug and precautionary information that will enable the patient to use the drug safely, such as a caution against driving or using other substances concomitantly. Comprehensive patient labeling should not be required for any—much less every—prescription drug.The four prototypes that the FDA previewed at its September workshop would seem to satisfy Pfizer and anyone else concerned about the potential complexity of consumer risk communication. The question is whether a one- or two-page sheet would replace the MedGuides and PPIs. Marcie Bough, Director of Federal Regulatory Affairs at the American Pharmaceutical Association, says: We support the development of a single, easy-to-read document that could be used to replace, not be added to, the current dispensing of MedGuides, CMI, and PPIs. However, we recognize that there may be some medications that fall outside of the single-document, one- to two-page format generally being discussed.Although most industry groups seem to agree on the need for a single, short consumer communication format, the American Society of Health-System Pharmacists (ASHP) wants a new CMI format to also include benefits of the medications. Justine Coffey, JD, LLM, ASHP Director of Federal Regulatory Affairs, says: To date, there has been a greater emphasis on the communication of risk information in CMI. Risk and benefit information should be communicated together in CMI, clearly describing any factors or contributing conditions that should be included in the patient/prescriber decision.The FDA might not be willing to adjust that balance, though, since the function of CMI, set in law, is to act as a “blinking yellow light” of sorts. The fact that a drug is approved means that it has benefits. But just as motorists slow down and watch for pedestrians or other cars before crossing an intersection with a blinking yellow light, patients are supposed to read the CMI before taking a drug." @default.
- W68807753 created "2016-06-24" @default.
- W68807753 creator A5036235042 @default.
- W68807753 date "2010-02-01" @default.
- W68807753 modified "2023-09-28" @default.
- W68807753 title "FDA Plans to Simplify Formats For Consumer Pharmacy Materials" @default.
- W68807753 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2827915" @default.
- W68807753 hasPublicationYear "2010" @default.
- W68807753 type Work @default.
- W68807753 sameAs 68807753 @default.
- W68807753 citedByCount "1" @default.
- W68807753 countsByYear W688077532012 @default.
- W68807753 crossrefType "journal-article" @default.
- W68807753 hasAuthorship W68807753A5036235042 @default.
- W68807753 hasConcept C104863432 @default.
- W68807753 hasConcept C108170787 @default.
- W68807753 hasConcept C112698675 @default.
- W68807753 hasConcept C144024400 @default.
- W68807753 hasConcept C144133560 @default.
- W68807753 hasConcept C159110408 @default.
- W68807753 hasConcept C160735492 @default.
- W68807753 hasConcept C17744445 @default.
- W68807753 hasConcept C199539241 @default.
- W68807753 hasConcept C2426938 @default.
- W68807753 hasConcept C2777351106 @default.
- W68807753 hasConcept C2777363581 @default.
- W68807753 hasConcept C2778858636 @default.
- W68807753 hasConcept C2779457091 @default.
- W68807753 hasConcept C36289849 @default.
- W68807753 hasConcept C39549134 @default.
- W68807753 hasConcept C509550671 @default.
- W68807753 hasConcept C512399662 @default.
- W68807753 hasConcept C71924100 @default.
- W68807753 hasConceptScore W68807753C104863432 @default.
- W68807753 hasConceptScore W68807753C108170787 @default.
- W68807753 hasConceptScore W68807753C112698675 @default.
- W68807753 hasConceptScore W68807753C144024400 @default.
- W68807753 hasConceptScore W68807753C144133560 @default.
- W68807753 hasConceptScore W68807753C159110408 @default.
- W68807753 hasConceptScore W68807753C160735492 @default.
- W68807753 hasConceptScore W68807753C17744445 @default.
- W68807753 hasConceptScore W68807753C199539241 @default.
- W68807753 hasConceptScore W68807753C2426938 @default.
- W68807753 hasConceptScore W68807753C2777351106 @default.
- W68807753 hasConceptScore W68807753C2777363581 @default.
- W68807753 hasConceptScore W68807753C2778858636 @default.
- W68807753 hasConceptScore W68807753C2779457091 @default.
- W68807753 hasConceptScore W68807753C36289849 @default.
- W68807753 hasConceptScore W68807753C39549134 @default.
- W68807753 hasConceptScore W68807753C509550671 @default.
- W68807753 hasConceptScore W68807753C512399662 @default.
- W68807753 hasConceptScore W68807753C71924100 @default.
- W68807753 hasIssue "2" @default.
- W68807753 hasLocation W688077531 @default.
- W68807753 hasOpenAccess W68807753 @default.
- W68807753 hasPrimaryLocation W688077531 @default.
- W68807753 hasRelatedWork W129406035 @default.
- W68807753 hasRelatedWork W1458824523 @default.
- W68807753 hasRelatedWork W1971259066 @default.
- W68807753 hasRelatedWork W1977539743 @default.
- W68807753 hasRelatedWork W2085805805 @default.
- W68807753 hasRelatedWork W2103928570 @default.
- W68807753 hasRelatedWork W2127996309 @default.
- W68807753 hasRelatedWork W2128437103 @default.
- W68807753 hasRelatedWork W2162978005 @default.
- W68807753 hasRelatedWork W2202917426 @default.
- W68807753 hasRelatedWork W2288254976 @default.
- W68807753 hasRelatedWork W2410418524 @default.
- W68807753 hasRelatedWork W2911424203 @default.
- W68807753 hasRelatedWork W303706 @default.
- W68807753 hasRelatedWork W324884557 @default.
- W68807753 hasRelatedWork W49522911 @default.
- W68807753 hasRelatedWork W177650825 @default.
- W68807753 hasRelatedWork W178843955 @default.
- W68807753 hasRelatedWork W1841428428 @default.
- W68807753 hasRelatedWork W2099307646 @default.
- W68807753 hasVolume "35" @default.
- W68807753 isParatext "false" @default.
- W68807753 isRetracted "false" @default.
- W68807753 magId "68807753" @default.
- W68807753 workType "article" @default.